Enzo Life Sciences Exendin-4 GLP-1 receptor agonist
Exendin-4 is a 39 aa polypeptide and incretin mimetic which was first isolated from Gila monster saliva. The synthetic form, Exenatide, is a glucagon like peptide-1 (GLP-1) agonist approved for the treatment of diabetes mellitus type II.
Research shows Exendin-4 is involved in glucose-dependent enhancement of insulin secretion, reduction of hyperglycemia, glucose-dependent suppression of inappropriately high glucagon secretion, slowing of gastric emptying and reduction of food intake, often with body weight reduction or blunting of weight gain.
Phone: 02 4575 0309
Echelon Biosciences ionisable lipids
Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...
BioStatus CyTRAK Orange fluorescent dye
BioStatus's CyTRAK Orange is a novel fluorescent dye that preferentially stains the nucleus...
Bio-Rad Laboratories anti-idiotypic antibodies and Human IgM-FcSpyCatcher reagent
Bio-Rad Laboratories has extended its range of recombinant monoclonal anti-idiotypic antibodies...
Learn More
I am interested in Enzo Life Sciences Exendin-4 GLP-1 receptor agonist.
Complete the form and a supplier representative will be in touch.
